skip to Main Content
Issue Areas
Forums
Blog
Connect With Us
About Us
2021 Snapshot
About IHP
Meet the Team
Contributing Authors
Search
Search
Submit
Issue Areas
Mental Health and Wellness
Children and Youth
INTRO STATEMENT
Learn more
Kaiser Permanente believes it is time for a new legal and policy landscape for drug pricing that rewards innovation and discovery, but also provides medicines at prices patients and the health care system can afford.
Featured content
Events
Our experts
Featured content
Events
Addressing Trauma in School-Aged Children
Drug pricing presenters
Click a speaker to view their full bio.
Barbara DiPietro, MD
Senior Director of Policy, National Health Care for the Homeless Council
Margot Kushel, MD
Director of the UCSF Benioff Homelessness and Housing Initiative
Rishi Manchanda, MD
President & CEO, HealthBegins
Cecilia Oregón, MPP, MPH
Executive Director, Kaiser Permanente Institute for Health Policy
Jacqueline Waggoner
President, Solutions Division, Enterprise Community Partners, Inc.
previous post:
Bringing High-Value Therapies to Patients
next post:
Health Care Workforce
Back To Top
2021 Snapshot is here!
CLOSE
Institute for Health Policy
2021 Snapshot
See how we met the moment in 2021
CLOSE